InsiderTrades

Form 4 for ADMA ADMA BIOLOGICS, INC.

Accepted 2026-03-10 00:00:00 ET · period of report 2026-03-06 · accession 0001140361-26-008905 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-03-10 2026-03-06+ ADMA Kestenberg-Messina Kaitlin M. COO, SVP, Compliance F - Tax $15.39 -14.3K 557.9K -2% -$220.0K
D 2026-03-10 2026-03-09 ADMA Kestenberg-Messina Kaitlin M. COO, SVP, Compliance J - Other $0.00 -91.3K 466.6K -16% $0
DM 2026-03-10 2026-03-09 ADMA Kestenberg-Messina Kaitlin M. COO, SVP, Compliance M - OptEx $3.20 +10.1K 474.5K +2% +$32.3K
D 2026-03-10 2026-03-09 ADMA Kestenberg-Messina Kaitlin M. COO, SVP, Compliance S - Sale+OE $15.63 -10.1K 466.6K -2% -$157.8K
DM 2026-03-10 2026-03-09 ADMA Kestenberg-Messina Kaitlin M. COO, SVP, Compliance M - OptEx $0.00 -10.1K 2,225 -82% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-06 F D 10,059 $15.39 562,101 D — — (F1) Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units ("RSUs"). This is not an open market sale of securities.
2 Common Common Stock 2026-03-07 F D 4,235 $15.39 557,866 D — — (F1) Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units ("RSUs"). This is not an open market sale of securities.
3 Common Common Stock 2026-03-09 J D 91,266 $0.00 466,600 D — —
4 Common Common Stock 2026-03-09 M A 2,500 $5.00 469,100 D — —
5 Common Common Stock 2026-03-09 M A 1,250 $4.31 470,350 D — —
6 Common Common Stock 2026-03-09 M A 2,646 $2.83 472,996 D — —
7 Common Common Stock 2026-03-09 S D 10,096 $15.63 466,600 D — — (F3) The securities were sold by the Reporting Person in accordance with the terms of the Divorce Settlement. (F4) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.59 to $15.65, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. (F5) Includes, as of the transaction date (i) 91,631 unvested RSUs granted on February 9, 2026, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 58,338 unvested RSUs out of 77,784 RSUs granted on February 19, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (iii) 144,240 unvested RSUs out of 192,320 RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date; (F6) (continued from footnote 5) (iv) 15,000 unvested RSUs out of 30,000 RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date; (v) 23,750 unvested RSUs out of 95,000 RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date; and (vi) 133,641 shares of common stock directly owned by the Reporting Person, which reflects prior option exercises and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.
8 Common Common Stock 2026-03-09 M A 2,175 $1.55 476,696 D — —
9 Common Common Stock 2026-03-09 M A 1,525 $2.35 474,521 D — —
10 Derivative Stock Option (right to buy) 2026-03-09 M D 2,500 $0.00 2,500 D $5.00 · — to 2027-02-14 2,500 Common Stock (F7) The incentive stock options were granted to the Reporting Person on February 14, 2017, and are fully vested.
11 Derivative Stock Option (right to buy) 2026-03-09 M D 2,175 $0.00 2,825 D $1.55 · — to 2031-07-19 2,175 Common Stock (F11) The incentive stock options were granted to the Reporting Person on July 19, 2021, and are fully vested.
12 Derivative Stock Option (right to buy) 2026-03-09 M D 1,250 $0.00 1,250 D $4.31 · — to 2029-06-05 1,250 Common Stock (F8) The incentive stock options were granted to the Reporting Person on June 5, 2019, and are fully vested.
13 Derivative Stock Option (right to buy) 2026-03-09 M D 2,646 $0.00 2,771 D $2.83 · — to 2030-08-19 2,646 Common Stock (F9) The incentive stock options were granted to the Reporting Person on August 19, 2020, and are fully vested.
14 Derivative Stock Option (right to buy) 2026-03-09 M D 1,525 $0.00 2,225 D $2.35 · — to 2031-02-25 1,525 Common Stock (F10) The incentive stock options were granted to the Reporting Person on February 25, 2021, and are fully vested.